Delivery Order SPE2DB24D1021-SPE2DB24FEUBU

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $4,759.11 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of August 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies,...
This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $76,499.29 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has a completion date of February 23, 2023 and was not set aside for any specific business designation. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for various federal healthcare programs, particularly...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Biktarvy 50-200-25 mg tablets. The $8,131.25 firm fixed price delivery order has an ultimate completion date of October 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a...
This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablet, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,964.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of May 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor. The $30,867.75 delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, to support military treatment programs and facilities. The contract has an ultimate completion date of October 11, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablets. The $29,476.02 firm fixed-price delivery order has a completion date of July 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The $43,139.50 firm fixed-price delivery order has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablet, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $39,380.91 delivery order contract with Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price agreement with a period of performance through December 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order valued at $12,364.74, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract covers the supply of Biktarvy 50-200-25 mg tablets to support military healthcare programs. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $26,895.33, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that supplies a wide range of medical products to federal agencies, including the Department of Defense and Veterans Affairs healthcare systems. The contract is a delivery order placed under Amerisourcebergen's existing...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FEUBU
    Delivery Order

This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $33,199 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract has an ultimate completion date of September 16, 2024.

Amerisourcebergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of pharmaceutical products and medical supplies in support of military treatment facilities, veterans' healthcare programs, and other government healthcare initiatives. The company's extensive supply chain and distribution capabilities enable it to fulfill essential medical requirements for federal agencies across the United States.

Generated 12/13/24, 9:11 AM